AT2221 Pill - gray & white capsule/oblong, 18mm
Generic Name: miglustat
Pill with imprint AT2221 is Gray & White, Capsule/Oblong and has been identified as Opfolda 65 mg. It is supplied by Amicus Therapeutics, Inc.
Opfolda is used in the treatment of Pompe Disease and belongs to the drug class miscellaneous metabolic agents. Risk cannot be ruled out during pregnancy. Opfolda 65 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for AT2221
Opfolda
- Generic Name
- miglustat
- Imprint
- AT2221
- Strength
- 65 mg
- Color
- Gray & White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous metabolic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amicus Therapeutics, Inc.
- National Drug Code (NDC)
- 71904-0300
See also:
Myozyme
Myozyme is used to treat a glycogen storage disorder called Pompe disease. Learn about side ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Zavesca
Zavesca is used in the treatment of mild to moderate type 1 Gaucher disease. Learn about side ...
Lumizyme
Lumizyme (alglucosidase alfa) is used to treat a glycogen storage disorder called Pompe disease ...
Pombiliti
Pombiliti (cipaglucosidase alfa-agta) is an intravenous infusion that is given over approximately 4 ...
More about Opfolda (miglustat)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.